Health Canada approves new antibody drug to help prevent serious RSV in babies

Nirsevimab is “a monoclonal antibody to prevent serious lower respiratory tract disease caused by respiratory syncytial virus infection in newborns and infants during their first RSV season,” Health Canada spokesman Mark Johnson said in an email to The Canadian Press on Friday.

Nirsevimab attaches to a protein on the surface of the virus and hinders its ability to enter the body’s cells, especially thosein the lungs, according to the European Medicines Agency,a regulatory body that last fall approved the drug for use in the European Union. “It’s a game-changer,” said Dr. Anna Banerji, a pediatric infectious disease specialist at the University of Toronto’s Dalla Lana School of Public Health.Many become seriously ill each year and have to be transported out of remote communities to hospitals in the south, she said.Although Health Canada has authorized nirsevimab for all infants, it’s not known whether it will be that widely administered.

On Friday, the CADTH website said its review of the “cost-effectiveness of nirsevimab for prevention of respiratory syncytial virus outcomes in infants” is “in progress.”

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Health Canada approves new antibody drug to help prevent serious RSV in babiesHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.
Source: CTVNews - 🏆 1. / 99 Read more »

Health Canada approves new antibody drug to help prevent serious RSV in babiesHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Source: CP24 - 🏆 30. / 67 Read more »

‘It’s a game-changer’: New drug to protect babies from RSV approved - National | Globalnews.caHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Source: GlobalNational - 🏆 81. / 51 Read more »

First Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths - Terrace StandardFirst Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths
Source: TerraceStandard - 🏆 24. / 68 Read more »